Barcelona, Spain

Marta Mir Cepeda

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Almirall, S.a.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marta Mir Cepeda. Retrieved from https://idiyas.com/inventor/marta-mir-cepeda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marta Mir Cepeda: Innovator in Pharmaceutical Chemistry

Introduction

Marta Mir Cepeda is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel therapeutic agents.

Latest Patents

Marta holds a patent for "Pyrrolotriazinone derivatives as PI3K inhibitors." This patent discloses new pyrrolotriazinone derivatives characterized by a specific chemical structure, which are utilized as inhibitors of Phosphoinositide 3-Kinases (PI3Ks). The patent also outlines the processes for their preparation, pharmaceutical compositions that include these compounds, and their therapeutic applications.

Career Highlights

Marta is currently employed at Almirall, S.A., a company known for its focus on dermatology and other therapeutic areas. Her work has been instrumental in advancing the understanding and treatment of various diseases through innovative chemical compounds.

Collaborations

Marta collaborates with notable colleagues, including Montserrat Erra Sola and Marta Carrascal Riera. These partnerships enhance the research and development efforts within her team, fostering a collaborative environment that drives innovation.

Conclusion

Marta Mir Cepeda exemplifies the spirit of innovation in pharmaceutical chemistry through her groundbreaking work and patent contributions. Her dedication to developing new therapeutic agents continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…